Researchers at the Scripps Research Institute in San Diego and Vanderbilt University have discovered a “missing link” in the structure of a transmembrane receptor that could lead to new treatments for autism, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Amish populations are valuable for genetic research because of their isolation, shared ancestry and homogeneous lifestyles.

These stories from the past year show how Vanderbilt is making an impact, on campus and in the world.

Eating fava beans increases dopamine in blood and urine, but does not stimulate urinary sodium excretion.

Researchers at Vanderbilt University have discovered a new “push-pull” mechanism in the brain that one day could lead to new treatments for movement disorders such as Parkinson’s disease, as well as stress-related disorders and addiction.

Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.